RoosterBio
Latest round
- Series B
Last raised
- Sep 2019
Total raised
- $22M
Investors
- 3
About RoosterBio
RoosterBio, Inc. focuses on providing adult human mesenchymal stem/stromal cells (hMSCs) and related products.RoosterBio’s primary offerings include adult human mesenchymal stem/stromal cells (hMSCs) and associated bioprocess media aimed at enhancing therapeutic technology commercialization. Their products, which derive from various tissues such as bone marrow, adipose tissue, and umbilical cord, come with advanced media for efficient cell expansion and exosome production, catering to clients in over 25 countries across six continents.The company generates revenue through a business-to-business (B2B) model, primarily from sales of hMSC systems, bioprocess media, and related services. Their flagship offerings, such as QuickShip™, facilitate tailored orders for specific tissue types, enhancing procurement efficiency. The pricing is contingent upon product specifications and volumes, with products compliant with cGMP regulations, allowing clients to obtain clinically relevant quantities promptly. The company is also set to strategically enter new markets, focusing on expansion into Europe and Asia by 2022.
Who invested in RoosterBio
3 investors across 2 rounds
See all investors in RoosterBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RoosterBio
Who invested in RoosterBio?
RoosterBio has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RoosterBio raised?
RoosterBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RoosterBio last raise money?
RoosterBio's most recent round on record is a Series B, in Sep 2019.
What does RoosterBio do?
RoosterBio is a biotechnology company.
Where is RoosterBio headquartered?
RoosterBio is headquartered in Frederick, US.
Which VCs invest in companies like RoosterBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RoosterBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like RoosterBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.